Antidepressants, eicosanoids and the prevention and treatment of cancer. A review

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 65, Issue 5-6, 2001, Pages 233-239

  Lieb, J ^a  

^a Woodbridge ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CYCLOOXYGENASE 2; ICOSANOID; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; THROMBOXANE;

ANGIOGENESIS; APOPTOSIS; AUTOIMMUNITY; CANCER PREVENTION; CANCER THERAPY; CARCINOGENESIS; CELL DIVISION; DEPRESSION; GENE EXPRESSION; IMMUNOSUPPRESSIVE TREATMENT; METASTASIS; ONCOGENE; PARANEOPLASTIC SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VIRUS ACTIVATION;

EID: 0035726147     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.2001.0319     Document Type: Article

References (139)

1. Prostaglandin secretion by medullary carcinoma of the thyroid
2. Prostaglandin-producing suppressor cells in Hodgkin's disease
3. Prostaglandin-like material extracted from squamous carcinomas of the head and neck
4. Prostaglandins in breast cancer: Relationship to disease stage and hormone status
5. Production of prostaglandins and thromboxane by isolated cells from intracranial tumors
6. Increased prostaglandin synthesis in Hodgkin's disease: A lymphocyte-monocyte interaction
7. Subversion of immune system by tumor cells and role of prostaglandins
8. 2 production by suppressor monocytes in head and neck cancer patients
9. The ability of macrophages from head and neck cancer patients to kill tumor cells: Effects of prostaglandin inhibitors on cytotoxicity
10. 2α in serum of bronchial carcinoma patients
11. Distribution of prostaglandins B, E and F series in plasma of cancer patients
12. Prostaglandins and their relationship to malignant and benign breast tumors
13. Prostaglandin regulation of murine mammary tumor virus production: A basis for some of the glucocorticoid and prolactin actions on mammary tumor cell cultures
14. Review: Prostaglandins and cancer
15. Cancer growth, response to treatment and survival time in mice: Beneficial effect of the prostaglandin synthesis inhibitor flurbiprofen
16. The role of prostaglandins in the development of malignant melanoma in hamsters
17. Endogenous prostaglandin production by established cultures of neoplastic rat mammary epithelial cells
18. Enhancement of carcinogenesis by prostaglandins
19. 2 synthesis or action on R 3230AC mammary carcinoma
20. Selected eicosanoids increase the proliferation of human colon carcinoma cell lines and mouse monocytes in vivo
21. Sulindac sulfide inhibits Ras signaling
22. Cyclooxygenase-2, a colorectal cancer nonsteroidal anti-inflammatory drug target, is regulated by c-MYB
23. 1 osteoblasts
24. 2: Comparison with chemotherapeutic agents
25. Evidence for c-AMP independent inhibition of S-phase DNA by prostaglandins
26. Inhibition of DNA synthesis and cell cycle by prostaglandins independent of cyclic AMP
27. Prostaglandin regulation of gene expression, growth in normal, malignant tissues
28. 2: A putative endogenous promoter of adipogenesis suppresses the ob gene
29. 2 modulation of p59fyntyrosine kinase in T-lymphocytes during sepsis
30. 2 in human neuroblastoma SK-N-BE(2)C cells
31. Activation of mitogen-activated protein kinase by fumonisin B(1) stimulates cPLA(2) phosphorylation, the arachidonic acid cascade and CAMP production
32. Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mutated protein kinase pathway
33. 2 regulates both interleukin-2 and granulocyte-macrophage colony-stimulating factor gene expression in bovine lymphocytes
34. The association between a mutated ras gene and cyclooxygenase-2 expression in human breast cancer cell lines
35. The role of cyclooxygenases in inflammation, cancer and development
36. Molecular pathology of cyclooxygenase-2 in neoplasia
37. Cyclooxygenase-2 expression is upregulated in squamous cell carcinoma of the head and neck
38. Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas
39. Expression and localization of cyclooxygenase isoforms in non-small cell lung cancer
40. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: Growth inhibition by nonsteroidal anti-inflammatory drugs
41. Helicobacter pylori infection induces cyclooxygenase-2 expression in human gastric mucosa
42. Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma
43. Expression of cyclooxygenase-2 in prostatic carcinoma
44. Human mesothelioma samples overexpress both cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (NOS2): In vitro antiproliferative effects of a COX-2 inhibitor
45. Cyclooxygenase-2 inhibitors in tumorigenesis (part 1)
46. Skin cancers in xeroderma pigmentosum: Response to indomethacin and steroids
47. Aspirin use and reduced risk of fatal colon cancer
48. Prostaglandins of the F series are extremely powerful growth factors for primary neonatal rat hepatocytes
49. Prostaglandins and the dog stomach: Effects of misoprostol on the proportion of mucosa to muscle and on the proportion of different epithelial type cells
50. 1 inhibits DNA synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factor
51. Eicosanoid effects on cell proliferation in vitro: Relevance to atherosclerosis
52. Stimulation of apoptosis by sulindac and piroxicam
53. Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines
54. Induction of apoptotic DNA fragmentation by nonsteoidal anti-inflammatory drugs in cultured rat gastric mucosal cells
55. MK-886, a leukotriene biosynthesis inhibitor induces antiproliferative effects and apoptosis in HL-60 cells
56. 1 transported into cells blocks the apoptotic signals induced by nerve growth factor deprivation
57. Interaction of cyclooxygenases with an apoptosis- and autoimmunity-associated protein
58. Differential effect of prostaglandins and other products of arachidonic acid metabolism on measles virus replication in vero cells
59. Human immunodeficiency virus glycoprotein (gp 120) induction of monocyte arachidonic acid and interleukin 1
60. Prostanoids and their role in cell-cell interactions in the central nervous system
61. Disruption of the antiproliferative TGF-β signaling pathways in human pancreatic cancer cells
62. 2. Role of early growth response protein-1 (Egr-1)
63. Regulation of arachidonic acid release and prostaglandin formation cell-to-cell adhesive interactions in wound repair
64. Malignant lymphoma in systemic rheumatic diseases. A report of five cases
65. Cancer and autoimmune diseases
66. Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis
67. 2
68. Prostaglandin modulation of development of cell-mediated immunity in culture
69. Metabolic immunosuppression which increases the risk of cancer
70. Impaired cell-mediated immunity in patients with cancer
71. Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: An 11-year follow up study of a general population
72. Natural selection and early changes of phenotype of tumor cells in vivo: Acquisition of new defense mechanisms
73. Tumor angiogenesis inhibition by prostaglandin synthase inhibitors
74. COX-2, iNOS and p53 as playmakers of tumor angiogenesis
75. Tumor cell-endothelial cell interactions: Evidence for roles for lipoxygenase products of arachidonic acid in metastasis
76. Inhibition of experimental metastasis with indomethacin: Role of macrophages and natural killer cells
77. Role of prostaglandins in metastatic dissemination of cancer: Minireview on cancer research
78. 2 is a mediator of cyclooxygenase dependent endothelial migration and angiogenesis
79. Interactions of natural effector cells and prostaglandins in the control of metastasis
80. 2 controls pulmonary metastasis of malignant melanoma cells
81. Thromboxane synthase and organ preference for metastases
82. Modulation of tumor cell adherence by prostaglandins
83. Prostacyclin: A potent antimetastatic agent
84. Enhancement of chemotherapeutic drug toxicity to human tumor cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs)
85. Prostaglandins as mediators of bone resorption in renal and breast tumors
86. 2 affects the tumor immune response in prostatic cancer
87. Cure of human melanoma lung metastases in nude mice with chronic indomethacin therapy combined with multiple rounds of IL-2: Characteristics of killer cells generated in situ
88. A hypothesis: Non-steroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer
89. Paraneoplastic syndromes
90. Autoimmune basis for visual paraneoplastic syndrome in patients with small-cell lung carcinoma
91. 2 in depression
92. CSF prostaglandin levels in depressed and schizophrenic patients
93. Increased level of salivary prostaglandins in patients with major depression
94. 2 by the antidepressant tranylcypromine
95. Depression and prostacyclin infusion
96. 3 on the central nervous system
97. Lithium as a regulator of hormone-stimulated prostaglandin synthesis
98. 1 and norepinephrine effects on cyclic adenosine monophosphate production in human platelets
99. 1 stimulated adenyl cyclase activity of human platelets
100. Lithium decreases turnover of arachidonate in several brain phospholipids
101. The influence of psychotropic drugs on prostaglandin biosynthesis
102. Tranylcypromine and 15-hydroperoxyarachidonate effect arachidonic acid release in addition to inhibition of prostacyclin synthesis in calf aortic endothelial cells
103. Chloroquine, quinine, procaine, quinidine and clomipramine are prostaglandin agonists and antagonists
104. 2
105. Effects of two antidepressant drugs-imipramine and amitriptyline on the enzyme activity of 15-hydroxyprostaglandin dehydrogenase purified from brain, lung, liver and kidney of mouse
106. The human heritage (the Ward Jones lecture, Manchester University)
107. Chronically depressed mood and cancer risk in older persons
108. Remission of rheumatoid arthritis and other disorders of immunity in patients taking monoamine oxidase inhibitors
109. Tricyclic antidepressants in the treatment of cancer pain: A review
110. Amitriptyline potentiates morphine analgesia by direct action on the central nervous system
111. Psychotropic adjuvant analgesics for pain in cancer and AIDS
112. Invisible antivirals
113. Does phenelzine relieve aphthous ulcers of the mouth?
114. The antiherpetic effect of phenelzine
115. MAO inhibitors
116. Inhibition of monoamine oxidase in chickens and ducklings by a microbial metabolite of furazolidone
117. Antidepressants cause lethal disruption of membrane function in the human protozoan parasite Leishmania
118. Antidepressant drugs suppress growth of the human pathogenic protozoan Giardia lamblia
119. Reversal of chloroquine resistance in malaria parasite Plasmodium falciparum by desipramine
120. Desipramine reversal of chloroquine resistance in wild isolates of Plasmodium falciparum
121. The prevalence and detection of psychiatric morbidity in patients with metastatic breast cancer
122. Depression in cancer patients: A literature review
123. Diagnosis and treatment of depression in cancer patients
124. Successful antidepressant treatment for five terminally ill cancer patients with major depression suicidal ideation and a desire for death
125. Depression and degree of acceptance of adjuvant cytotoxic drugs
126. Remission of recurrent herpes during therapy with lithium
127. A possible antiviral action of lithium carbonate in herpes simplex virus infections
128. 1 may explain its antiviral, immunopotentiating and antimanic properties
129. Lithium and immune function
130. The effect of lithium chloride on the replication of herpes simplex virus
131. Manic illness presenting with physical symptoms
132. Cancer morbidity in psychiatric patients: Influence of lithium carbonate treatment
133. Effect of lithium gamma-linolenate on the growth of experimental human pancreatic carcinoma
134. The effect of lithium carbonate on leukopenia after chemotherapy
135. Antidepressant tachyphylaxis
136. Antitumor marine icosanoids: Clavulones and punaglandins
137. Antineoplastic prostaglandin, antitumor effect of PGA, PGJ derivatives
138. Antidepressant medication use and breast cancer risk
139. Paradoxical worsening of depressive symptomatology caused by antidepressants